| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |